Literature DB >> 1981408

Results of the First International Granulocyte Serology Workshop.

G F Lucas1, P A Carrington.   

Abstract

Eleven laboratories participated in the First International Workshop of Granulocyte Serology. Participants were asked to identify any granulocyte-reactive antibodies present in 12 human sera distributed as unknown samples. Granulocyte immunofluorescence and granulocyte micro-agglutination were the most commonly used techniques. The incidence of false-positive and false-negative reactions was 15 and 4%, respectively. Most laboratories were able to distinguish between granulocyte-specific and anti-HLA antibodies using platelet absorption. The identification of the specificity of granulocyte-specific antibodies caused the most problems; these were correctly identified on only 57% of occasions.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1981408     DOI: 10.1111/j.1423-0410.1990.tb00249.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  5 in total

Review 1.  Diagnosis and management of primary autoimmune neutropenia in children: insights for clinicians.

Authors:  Piero Farruggia; Carlo Dufour
Journal:  Ther Adv Hematol       Date:  2015-02

2.  Autoimmune neutropenia of infancy.

Authors:  E G Lyall; G F Lucas; O B Eden
Journal:  J Clin Pathol       Date:  1992-05       Impact factor: 3.411

3.  Novel enzyme-linked immunosorbent assays for the detection of anti-Fc gamma receptor autoantibodies.

Authors:  A Lamour; R LeCorre; C Jamin; C Soubrane; D Khayat; P Youinou
Journal:  Clin Diagn Lab Immunol       Date:  1996-05

4.  Iso-immune neonatal neutropenia due to an anti-Fc receptor III (CD16) antibody.

Authors:  J Cartron; J L Celton; P Gane; A Astier; W H Fridman; G Boissinot; J P Cartron
Journal:  Eur J Pediatr       Date:  1992-06       Impact factor: 3.183

5.  Reduction of CFU-GM and circulating hematopoietic progenitors in a subgroup of children with chronic neutropenia associated with severe infections and delayed recovery.

Authors:  Fabio Timeus; Nicoletta Crescenzio; Luiselda Foglia; Alessandra Doria; Maria Giuseppina Stillitano; Emanuela Garelli; Raffaela Mazzone; Laura Vivalda; Stefano Vallero; Ugo Ramenghi; Paola Saracco
Journal:  PLoS One       Date:  2019-03-14       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.